Investor Relations

Investor Relations

Learn about investment opportunities in our healthcare platform company focused on infusion therapy consolidation.

Investment Highlights

  • Fragmented Market: The infusion therapy market in South Florida is highly fragmented, with numerous independent providers generating $500K-$3M in annual EBITDA.
  • Disciplined Acquisition Strategy: We target high-quality providers at 3-5x EBITDA multiples, significantly below the 7-10x multiples commanded by scaled platforms.
  • Operational Improvements: Our systematic 100-day integration plan captures immediate synergies and establishes operational improvements.
  • Multiple Expansion: By building sufficient scale (typically $15-20M in EBITDA), we position the platform for exit at 7-10x EBITDA.
  • Experienced Leadership: Our management team and board bring extensive experience in healthcare operations, M&A, and value creation.
  • Clear Exit Strategy: We have a defined 3-5 year investment horizon with multiple potential exit options.

Investment Timeline

Our investment strategy follows a clear timeline with defined milestones.

Year 1

  • Initial capital raise
  • First 2-3 acquisitions
  • Implementation of integration playbook
  • Establishment of centralized functions
  • Development of standardized protocols

Years 2-3

  • Additional 4-6 acquisitions
  • Optimization of operations
  • Implementation of growth initiatives
  • Expansion of service offerings
  • Beginning of quarterly distributions

Years 4-5

  • Final 2-3 acquisitions
  • Refinement of operations
  • Preparation for exit
  • Enhancement of financial reporting
  • Development of exit marketing materials

Exit

  • Engagement of investment banker
  • Marketing to potential acquirers
  • Negotiation of sale terms
  • Completion of transaction
  • Distribution of proceeds to investors

Financial Targets

25-35%
Target IRR
3-4x
Cash-on-Cash Multiple
3-5x
Acquisition Multiples
7-10x
Target Exit Multiple

Investment Opportunities

We offer several investment options for qualified investors interested in participating in our infusion therapy rollup strategy.

Equity Investment

Minimum: $250,000

Target Returns: 25-35% IRR

Structure: Limited Partnership

Distributions: Quarterly beginning in year 2

Liquidity: 3-5 year investment horizon

Preferred Equity

Minimum: $500,000

Target Returns: 8% current yield + equity participation

Structure: Preferred Units

Distributions: Quarterly from inception

Liquidity: 3-5 year investment horizon

Debt Investment

Minimum: $100,000

Target Returns: 10-12% fixed yield

Structure: Secured Notes

Distributions: Quarterly from inception

Liquidity: 2-3 year term

Scroll to top